DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydrocortisone (Hydrocortisone Topical) - Hypertension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypertension (17)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) where reactions include hypertension. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate Sodium
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-16

Patient:

Reactions: Off Label Use, Hypotension, Hypertension

Drug(s) suspected as cause:
Bortezomib
    Dosage: per dose on days 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 or days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: per day divided into 2 doses was given orally for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: on day 15 or days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

PEG-Asparaginase
    Dosage: 2500 units/m2/dose was given intramuscularly as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: per dose (2 mg maximum dose) was administered intravenously by push on day 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Hydrocortisone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2

Cyclophosphamide
    Dosage: 300 mg/m2 as part of cop
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: continuous infusion of 100 mg/m2 daily for 5 days
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: administered once with hydrocortisone as part of cym1

Doxorubicin HCL
    Dosage: as part of copadm1
    Indication: Burkitt's Lymphoma Stage III

Doxorubicin HCL
    Dosage: as part of copadm2

Hydrocortisone
    Dosage: administered with methotrexate
    Indication: Burkitt's Lymphoma Stage III

Hydrocortisone
    Dosage: administered once with cytarabine as part of cym1

Methotrexate
    Dosage: 3000 mg/m2; administered with hydrocortisone
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: as part of copadm1

Methotrexate
    Dosage: as part of copadm2 and cym1

Prednisolone
    Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2

Prednisolone
    Dosage: 60 mg/m2/day for 7 days as part of cop
    Indication: Burkitt's Lymphoma Stage III

Rituximab
    Dosage: five total doses; cumulative dose of 1875 mg/m2
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: as part of copadm1

Vincristine
    Dosage: as part of copadm2

Vincristine
    Dosage: as part of cop
    Indication: Burkitt's Lymphoma Stage III



Possible Hydrocortisone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 300 mg/m2 as part of cop
    Indication: Burkitt's Lymphoma Stage III

Cyclophosphamide
    Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2

Cytarabine
    Dosage: continuous infusion of 100 mg/m2 daily for 5 days
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: administered once with hydrocortisone as part of cym1

Doxorubicin HCL
    Dosage: as part of copadm1
    Indication: Burkitt's Lymphoma Stage III

Doxorubicin HCL
    Dosage: as part of copadm2

Hydrocortisone
    Dosage: administered once with cytarabine as part of cym1

Hydrocortisone
    Dosage: administered with methotrexate
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: as part of copadm1

Methotrexate
    Dosage: as part of copadm2 and cym1

Methotrexate
    Dosage: administered with hydrocortisone
    Indication: Burkitt's Lymphoma Stage III

Prednisolone
    Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2

Prednisolone
    Dosage: 60 mg/m2/day for 7 days as part of cop
    Indication: Burkitt's Lymphoma Stage III

Rituximab
    Dosage: five total doses; cumulative dose of 1875 mg/m2
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: as part of copadm2

Vincristine
    Dosage: as part of cop
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: as part of copadm1



Possible Hydrocortisone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: six doses as part of copadm1 and six doses as part of dose-reduced copadm2

Cyclophosphamide
    Dosage: 300 mg/m2 as part of cop
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: continuous infusion of 100 mg/m2 daily for 5 days
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: administered once with hydrocortisone as part of cym1

Doxorubicin HCL
    Dosage: as part of copadm1
    Indication: Burkitt's Lymphoma Stage III

Doxorubicin HCL
    Dosage: as part of copadm2

Hydrocortisone
    Dosage: administered once with cytarabine as part of cym1

Hydrocortisone
    Dosage: administered with methotrexate
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: as part of copadm2 and cym1

Methotrexate
    Dosage: administered with hydrocortisone
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: as part of copadm1

Prednisolone
    Dosage: 60 mg/m2/day for 7 days as part of cop
    Indication: Burkitt's Lymphoma Stage III

Prednisolone
    Dosage: 60 mg/m2/day for 5 days, then tapered over 3 days as part of copadm1 and copadm2

Rituximab
    Dosage: five total doses; cumulative dose of 1875 mg/m2
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: as part of copadm2

Vincristine
    Dosage: as part of copadm1

Vincristine
    Dosage: as part of cop
    Indication: Burkitt's Lymphoma Stage III



Possible Hydrocortisone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Pancytopenia, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 250 mg/m2, bid for 6 doses

Cyclophosphamide
    Dosage: 250 mg/m2, bid for 6 doses

Cyclophosphamide
    Dosage: 300 mg/m2, unk
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: 100 mg/m2, for 5 days
    Indication: Burkitt's Lymphoma Stage III

Cytarabine
    Dosage: unknown

Doxorubicin HCL
    Dosage: 30 mg/m2, unk

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Burkitt's Lymphoma Stage III

Hydrocortisone
    Indication: Burkitt's Lymphoma Stage III

Hydrocortisone
    Dosage: intrathecally twice

Hydrocortisone

Hydrocortisone
    Dosage: intrathecally twice

Hydrocortisone
    Dosage: unknwon

Methotrexate
    Dosage: 1500 mg/m2, unk

Methotrexate
    Indication: Burkitt's Lymphoma Stage III

Methotrexate
    Dosage: intrathecally twice

Methotrexate
    Dosage: intrathecally twice

Methotrexate
    Dosage: 1500 mg/m2, unk

Methotrexate
    Dosage: 30000 mg/m2, unk

Methotrexate

Prednisolone
    Dosage: 60 mg/m2, for 5 days, then taper over 3 days

Prednisolone
    Dosage: 60 mg/m2, for 5 days then taper over 3 days

Prednisolone
    Dosage: 60 mg/m2, per day for 7 days
    Indication: Burkitt's Lymphoma Stage III

Rituximab
    Dosage: every 2-4 weeks for 5 total doses with cumulative dose of 1875 mg/m2
    Indication: Burkitt's Lymphoma Stage III

Rituximab
    Dosage: cumulative dose of 1875 mg/m2

Vincristine
    Dosage: 2 mg/m2, unk

Vincristine
    Dosage: 1 mg/m2, unk
    Indication: Burkitt's Lymphoma Stage III

Vincristine
    Dosage: 1 mg/m2, unk



Possible Hydrocortisone side effects in 10 year old female

Reported by a individual with unspecified qualification from United States on 2012-04-26

Patient: 10 year old female

Reactions: Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: regimen copadm1, for 6 doses

Cyclophosphamide
    Dosage: regimen cop
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: regimen copadm2, for 6 doses

Cytarabine
    Dosage: regimen cym1,continuous infusion daily for 5 days
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: regimen copadm2

Doxorubicin HCL
    Dosage: regimen copadm1
    Indication: Burkitt's Lymphoma

Hydrocortisone
    Dosage: regimen cym1, methotrexate/hydrocortisone once and cytarabine/hydrocortisone once

Hydrocortisone
    Dosage: regimen copadm2, methotrexate/hydrocortisone twice

Hydrocortisone
    Dosage: regimen cop, methotrexate/hydrocortisone
    Indication: Burkitt's Lymphoma

Hydrocortisone
    Dosage: regimen copadm1, methotrexate/hydrocortisone twice

Methotrexate
    Dosage: regimen copadm2

Methotrexate
    Dosage: regimen copadm1,
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: regimen cym1

Prednisolone
    Dosage: regimen copadm1, for 5 days then taper over 3 days

Prednisolone
    Dosage: regimen copadm2, for 5 days then taper over 3 days

Prednisolone
    Dosage: regimen cop, for 7 days
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: every 2-4 weeks for 5 total doses, starting between copadm1 and copadm2
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: regimen copadm1

Vincristine
    Dosage: regimen cop
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: regimen copadm2



Possible Hydrocortisone side effects in female

Reported by a physician from Germany on 2012-02-22

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Headache, Horner's Syndrome, Haematemesis, Metastasis, Electrolyte Imbalance, Thrombocytopenia, Epistaxis, Back Pain, Vomiting, Adrenocortical Insufficiency Acute, Nausea, Anaemia, Neutropenic Sepsis, Hyponatraemia, Pancytopenia, Neoplasm Malignant, Disturbance in Attention, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: unk
    Indication: Neoplasm Malignant
    Start date: 2011-03-23
    End date: 2011-03-25

Etoposide
    Dosage: unk
    Indication: Neoplasm Malignant
    Start date: 2011-03-25
    End date: 2011-03-25

Hydrocortisone
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2008-12-15

Morphine

Som230
    Dosage: 60 mg, unk
    Indication: Neuroendocrine Tumour
    Start date: 2010-06-15
    End date: 2011-01-26

Voltaren
    Dosage: unk
    Start date: 2011-02-01

Other drugs received by patient: Zoledronic; Astonin-H



Possible Hydrocortisone side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-06

Patient: 69 year old female

Reactions: Acute Pulmonary Oedema, Herpes Simplex, Cytomegalovirus Infection, Cardiomyopathy, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Doxorubicin HCL
    Dosage: 50 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Hydrocortisone
    Dosage: 25 mg, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Mabthera
    Dosage: 375 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Methotrexate
    Dosage: 15 mg, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Prednisone TAB
    Dosage: unk
    Administration route: Oral
    Start date: 2011-07-07
    End date: 2011-07-10

Solu-Medrol
    Dosage: 40 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Vincristine Sulfate
    Dosage: 1.4 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06



Possible Hydrocortisone side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-01

Patient: 69 year old female

Reactions: Acute Pulmonary Oedema, Herpes Simplex, Cytomegalovirus Infection, Cardiomyopathy, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Doxorubicin HCL
    Dosage: 50 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Hydrocortisone
    Dosage: 25 mg, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Mabthera
    Dosage: 375 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Methotrexate
    Dosage: 15 mg, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Prednisone TAB
    Dosage: unk
    Administration route: Oral
    Start date: 2011-07-07
    End date: 2011-07-10

Solu-Medrol
    Dosage: 40 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Vincristine Sulfate
    Dosage: 1.4 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06



Possible Hydrocortisone side effects in female

Reported by a physician from Germany on 2011-11-17

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Headache, Horner's Syndrome, Haematemesis, Metastasis, Electrolyte Imbalance, Thrombocytopenia, Epistaxis, Back Pain, Vomiting, Nausea, Adrenocortical Insufficiency Acute, Neutropenic Sepsis, Anaemia, Hyponatraemia, Pancytopenia, Neoplasm Malignant, Disturbance in Attention, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: unk
    Indication: Neoplasm Malignant
    Start date: 2011-03-23
    End date: 2011-03-25

Etoposide
    Dosage: unk
    Indication: Neoplasm Malignant
    Start date: 2011-03-25
    End date: 2011-03-25

Hydrocortisone
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2008-12-15

Morphine

Som230
    Dosage: 60 mg, unk
    Indication: Neuroendocrine Tumour
    Start date: 2010-06-15
    End date: 2011-01-26

Voltaren
    Dosage: unk
    Start date: 2011-02-01

Other drugs received by patient: Astonin-H; Zoledronic



Possible Hydrocortisone side effects in female

Reported by a physician from Germany on 2011-11-11

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Headache, Haematemesis, Horner's Syndrome, Metastasis, Electrolyte Imbalance, Thrombocytopenia, Epistaxis, Back Pain, Vomiting, Nausea, Adrenocortical Insufficiency Acute, Anaemia, Pancytopenia, Hyponatraemia, Neoplasm Malignant, Disturbance in Attention, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Diclofenac Sodium
    Dosage: unk
    Start date: 2011-02-01

Hydrocortisone

Morphine

Som230
    Dosage: 60 mg, unk
    Indication: Neuroendocrine Tumour
    Start date: 2010-06-15
    End date: 2011-02-01

Other drugs received by patient: Astonin-H; Zoledronic



Possible Hydrocortisone side effects in 22 year old female

Reported by a physician from United States on 2011-11-10

Patient: 22 year old female

Reactions: White Blood Cell Count Decreased, Headache, Neutrophil Count Decreased, Hypertension, Enterocolitis Infectious, Fluid Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Asparaginase
    Indication: Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: 2400 mg total
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Cytarabine
    Indication: Lymphocytic Leukaemia

Dasatinib
    Dosage: 1400 mg
    Administration route: Oral
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Daunorubicin Hydrochloride
    Indication: Lymphocytic Leukaemia

Dexamethasone
    Administration route: Oral
    Indication: Lymphocytic Leukaemia

Etoposide
    Dosage: 800 mg total
    Indication: Lymphocytic Leukaemia
    Start date: 2011-05-28

Hydrocortisone
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Ifosfamide
    Indication: Lymphocytic Leukaemia

Mercaptopurine
    Dosage: 2475 mg total dose
    Administration route: Oral
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Methotrexate
    Dosage: 8127.5 mg total
    Administration route: Oral
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Metronidazole
    Indication: Lymphocytic Leukaemia

Pegaspargase
    Indication: Lymphocytic Leukaemia

Prednisone TAB
    Dosage: 600 mg
    Administration route: Oral
    Indication: Lymphocytic Leukaemia

Vincristine
    Indication: Lymphocytic Leukaemia



Possible Hydrocortisone side effects in 22 year old female

Reported by a physician from United States on 2011-11-10

Patient: 22 year old female

Reactions: White Blood Cell Count Decreased, Headache, Hypertension, Neutrophil Count Decreased, Fluid Retention, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 480 mg (total dose: 2400 mg: 300 mg/m2/dose)
    Start date: 2011-09-11

Cyclophosphamide
    Dosage: 2400 mg, unk
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Cytarabine
    Dosage: 60 mg, unk
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Cytarabine
    Dosage: 30 mg (total dose: 60 mg) given it
    Start date: 2011-09-07

Dasatinib
    Dosage: 1400 mg, unk
    Administration route: Oral
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Dasatinib
    Dosage: unk
    Start date: 2011-06-17

Dasatinib
    Dosage: 100 mg, 1x/day (total dose: 1400 mg) qd x 14 days (60 mg/m2/dose) on maintenance cycle 3
    Administration route: Oral
    Start date: 2011-09-20

Daunorubicin Hydrochloride
    Indication: Lymphocytic Leukaemia

Dexamethasone Sodium Phosphate
    Dosage: unk
    Administration route: Oral
    Indication: Lymphocytic Leukaemia

Dexamethasone Sodium Phosphate
    Dosage: 2 mg, on days 1 and 29 of maintenance cycle 3
    Start date: 2011-09-07

Elspar
    Indication: Lymphocytic Leukaemia

Etoposide
    Dosage: 160 mg (total dose 800 mg: 100 mg/m2/dose) on days 29-33
    Start date: 2011-09-11

Etoposide
    Dosage: 800 mg, unk
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Flagyl
    Dosage: unk
    Indication: Clostridium Difficile Colitis
    Start date: 2011-06-18
    End date: 2011-06-22

Hydrocortisone
    Dosage: 30 mg, unk
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Hydrocortisone
    Dosage: 15 mg (total dose: 30 mg)
    Start date: 2011-09-07

Ifosfamide
    Indication: Lymphocytic Leukaemia

Mercaptopurine
    Dosage: 125 mg x 5 days each week and 100 x 2 days each week, repeated for 3 weeks total (days 8-28)
    Start date: 2011-09-06

Mercaptopurine
    Dosage: 2475 mg, unk
    Administration route: Oral
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Methotrexate Sodium
    Dosage: 8127.5 mg, unk
    Administration route: Oral
    Indication: Lymphocytic Leukaemia
    Start date: 2010-05-28

Methotrexate Sodium
    Dosage: unk
    Start date: 2011-06-17

Methotrexate Sodium
    Dosage: 8000 mg (5000 mg/m2/dose) given as 24 hour infusion on day 1 and 15 mg it on days 1 and 29
    Start date: 2011-08-12

Pegaspargase
    Indication: Lymphocytic Leukaemia

Prednisone
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Lymphocytic Leukaemia
    Start date: 2011-06-17

Prednisone
    Dosage: 30 mg 2x/day (20 mg/m2/dose) on days 1-5 and on days 29-33 of maintenance cycle 3
    Administration route: Oral
    Start date: 2011-09-11

Vincristine Sulfate
    Dosage: 4 mg, unk
    Indication: Lymphocytic Leukaemia
    Start date: 2011-06-17



Possible Hydrocortisone side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-24

Patient: 69 year old female

Reactions: Acute Pulmonary Oedema, Herpes Simplex, Cytomegalovirus Infection, Cardiomyopathy, Hypertension, Acute Respiratory Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Doxorubicin HCL
    Dosage: 50 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Hydrocortisone
    Dosage: 25 mg, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Mabthera
    Dosage: 375 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Methotrexate
    Dosage: 15 mg, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Prednisone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-07-07
    End date: 2011-07-10

Solu-Medrol
    Dosage: 40 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

Vincristine Sulfate
    Dosage: 1.4 mg/m2, unk
    Indication: T-Cell Lymphoma Stage III
    Start date: 2011-07-06
    End date: 2011-07-06

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017